Roche to pay $7.1 bn for Telavant Holdings
Swiss pharmaceutical group Roche said Monday it will pay $7.1 billion to buy Telavant Holdings, a group developing new treatments for inflammatory bowel diseases.
Oct 23, 2023
0
48
Digestive System Diseases: News and Research on Colitis, Ulcerative
MeSH tree: C06.405.205.731.249
Transcutaneous auricular vagus nerve stimulation beneficial in pediatric IBD
For pediatric patients with mild-to-moderate inflammatory bowel disease, transcutaneous auricular vagus nerve stimulation (ta-VNS) attenuates signs and symptoms of disease, according to a study published online Oct. 18 in ...
Oct 20, 2023
0
50
FDA approves velsipity for moderate-to-severe ulcerative colitis in adults
The U.S. Food and Drug Administration has approved Velsipity (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).
Oct 18, 2023
0
50
Inflammatory bowel disease tied to higher risk for gout
Inflammatory bowel disease (IBD) is strongly associated with gout, according to a study published online Sept. 1 in JGH Open.
Oct 3, 2023
0
36
Study pinpoints specialized gut immune cells that can limit progression of inflammatory bowel disease
Researchers at the Francis Crick Institute, King's College London and Guy's and St Thomas' NHS Foundation Trust have characterized a specialized type of immune cell, which plays a key role in protecting and repairing the ...
Sep 14, 2023
0
245
Researchers identify driver of inflammatory bowel disease
Researchers at UT Southwestern Medical Center have discovered an intracellular mechanism that converts protective intestinal cells into disease-driving pathogenic cells, a finding that could lead to improved treatments for ...
Sep 13, 2023
0
174
Older adults with digestive diseases found to experience higher rates of loneliness, depression
While life expectancy rates for older Americans are rising, nearly 40% of adults report living with a digestive disease of some kind.
Sep 12, 2023
0
39
Health of young people with ulcerative colitis at risk as most stop taking medication within a year, finds study
Nearly 70 percent of adolescents and young adults with ulcerative colitis stop taking medication to treat the disease within a year of diagnosis.
Sep 12, 2023
0
40
Developing a less invasive test for inflammatory bowel disease
Millions of Americans have inflammatory bowel disease (IBD), which occurs in one of two forms: Crohn's disease or ulcerative colitis. Though the two have similar symptoms, they require different treatment strategies, and ...
Sep 7, 2023
0
53
Statins linked to lower risk of colorectal cancer in patients with ulcerative colitis
Cholesterol-lowering statins might protect patients with ulcerative colitis from developing and dying from colorectal cancer. Statin treatment was also associated with a lower risk of death regardless of cause in patients ...
Sep 1, 2023
0
101
